BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31989589)

  • 1. Low-dose IL-2 induces CD56
    McQuaid SL; Loughran ST; Power PA; Maguire P; Szczygiel A; Johnson PA
    Clin Exp Immunol; 2020 Jun; 200(3):228-241. PubMed ID: 31989589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells.
    Martin JF; Perry JS; Jakhete NR; Wang X; Bielekova B
    J Immunol; 2010 Jul; 185(2):1311-20. PubMed ID: 20543101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
    Laroni A; Armentani E; Kerlero de Rosbo N; Ivaldi F; Marcenaro E; Sivori S; Gandhi R; Weiner HL; Moretta A; Mancardi GL; Uccelli A
    J Autoimmun; 2016 Aug; 72():8-18. PubMed ID: 27157273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
    Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
    Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza A Virus Hemagglutinin and Other Pathogen Glycoprotein Interactions with NK Cell Natural Cytotoxicity Receptors NKp46, NKp44, and NKp30.
    Luczo JM; Ronzulli SL; Tompkins SM
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33494528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
    Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
    Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation.
    Hao J; Campagnolo D; Liu R; Piao W; Shi S; Hu B; Xiang R; Zhou Q; Vollmer T; Van Kaer L; La Cava A; Shi FD
    Ann Neurol; 2011 Apr; 69(4):721-34. PubMed ID: 21425186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance.
    Martner A; Rydström A; Riise RE; Aurelius J; Brune M; Foà R; Hellstrand K; Thorén FB
    Oncotarget; 2015 Dec; 6(40):42569-74. PubMed ID: 26544512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
    Campos C; López N; Pera A; Gordillo JJ; Hassouneh F; Tarazona R; Solana R
    Biogerontology; 2015 Oct; 16(5):671-83. PubMed ID: 25991472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions.
    Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q
    Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria.
    Esin S; Batoni G; Counoupas C; Stringaro A; Brancatisano FL; Colone M; Maisetta G; Florio W; Arancia G; Campa M
    Infect Immun; 2008 Apr; 76(4):1719-27. PubMed ID: 18212080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis.
    Li Z; Lim WK; Mahesh SP; Liu B; Nussenblatt RB
    J Immunol; 2005 May; 174(9):5187-91. PubMed ID: 15843513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Natural Cytotoxicity Receptor NKp44 (NCR2, CD336) Is Expressed on the Majority of Porcine NK Cells
    Mair KH; Crossman AJ; Wagner B; Babasyan S; Noronha L; Boyd P; Zarlenga D; Stadler M; van Dongen KA; Gerner W; Saalmüller A; Lunney JK
    Front Immunol; 2022; 13():767530. PubMed ID: 35154097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell cytokine response to M. bovis BCG Is associated with inhibited proliferation, increased apoptosis and ultimate depletion of NKp44(+)CD56(bright) cells.
    Portevin D; Young D
    PLoS One; 2013; 8(7):e68864. PubMed ID: 23874793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors.
    Hromadnikova I; Pirkova P; Sedlackova L
    Mediators Inflamm; 2013; 2013():405295. PubMed ID: 23476104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation.
    Marras F; Nicco E; Bozzano F; Di Biagio A; Dentone C; Pontali E; Boni S; Setti M; Orofino G; Mantia E; Bartolacci V; Bisio F; Riva A; Biassoni R; Moretta L; De Maria A
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11970-5. PubMed ID: 23818644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
    Nielsen N; Pascal V; Fasth AE; Sundström Y; Galsgaard ED; Ahern D; Andersen M; Baslund B; Bartels EM; Bliddal H; Feldmann M; Malmström V; Berg L; Spee P; Söderström K
    Immunology; 2014 Aug; 142(4):581-93. PubMed ID: 24673109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
    Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
    Front Immunol; 2021; 12():640672. PubMed ID: 34017328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.
    Jarahian M; Watzl C; Fournier P; Arnold A; Djandji D; Zahedi S; Cerwenka A; Paschen A; Schirrmacher V; Momburg F
    J Virol; 2009 Aug; 83(16):8108-21. PubMed ID: 19515783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells.
    Bergmann C; Wild CA; Narwan M; Lotfi R; Lang S; Brandau S
    Eur J Immunol; 2011 Dec; 41(12):3564-73. PubMed ID: 21905023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.